Skip to content

The Psychological Effects of Miscarriage Prediction Score: A Prospective Study

The Psychological Effects of Miscarriage Prediction Score: A Prospective Study

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07609602
Acronym
PEMPS
Enrollment
372
Registered
2026-05-27
Start date
2026-06-01
Completion date
2028-06-01
Last updated
2026-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early Pregnancy Bleeding

Brief summary

Patients Under 12 Weeks Pregnant With a Single Ongoing Pregnancy Attending the EPU Will be Randomly Assigned to Receive Their Personalised Miscarriage Risk Score or Not. The Study Explores Whether Sharing This Score Affects Anxiety and Whether Patients Find the Information Helpful and Acceptable. (PEMPS)

Detailed description

The PEMPS study is a prospective, randomised controlled investigation designed to evaluate the psychological impact of providing individualised miscarriage risk estimates to patients in early pregnancy. The study population comprises individuals attending an Early Pregnancy Unit (EPU) with a confirmed single ongoing intrauterine pregnancy under 12 weeks' gestation. Participants will be randomly allocated in a 1:1 ratio to either receive their personalised miscarriage risk score (intervention group) or to receive standard care without disclosure of such a score (control group). Randomisation will be implemented using a computer-generated allocation sequence with appropriate allocation concealment to minimize selection bias. The personalised miscarriage risk score will be derived using a validated predictive model incorporating relevant clinical and ultrasound parameters routinely collected during EPU assessment. The methodology underlying the risk calculation will remain consistent across participants to ensure comparability and reproducibility. Participants in the intervention arm will be provided with their individualised risk estimate in a standardised format, accompanied by a brief explanation to support interpretation. Care will be taken to ensure that the communication approach is clear, non-directive, and does not include additional counselling beyond standard clinical practice. Participants in the control arm will receive routine clinical information and follow-up as per standard EPU protocols, without access to the calculated risk score. The primary objective of the study is to determine whether disclosure of a personalised miscarriage risk score influences patient-reported anxiety levels in early pregnancy, assessed using a validated questionnaires on Day 0 and Day 7. The secondary objective is patient acceptability of the study using qualitative feedback on Day 7.

Interventions

OTHERWill not receive miscarriage prediction score

These patients will not receive a miscarriage prediction score

OTHERMiscarriage prediction score

Half of the patients will receive a uniquely calculated miscarriage prediction score based on symptoms and individual characteristics

Sponsors

King's College Hospital NHS Trust
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Have capacity to understand the study and to provide signed and dated informed consent. * Willing to comply with all study procedures and be available for the duration of the study including consenting to follow up of the pregnancy outcome by letter, phone or email according to individual preference. * Age 16 years or over * Single live ongoing intrauterine pregnancy less than 12 weeks gestation

Exclusion criteria

Women with pregnancies of unknown location, ectopic pregnancies or early pregnancy prior to an embryo being seen or an embryo without a heartbeat. * Multiple pregnancies * Those undergoing assessment or treatment for a psychological condition by a psychiatrist * Those who do not speak English or require a translator * Women who have taken part in another clinical trial in the last 3 months.

Design outcomes

Primary

MeasureTime frameDescription
To measure the psychological effects of the miscarriage prediction model7 daysThe study will measure patients' psychological wellbeing objectively using a composite psychological distress score. This composite score is derived by combining the Hospital Anxiety and Depression Scale (HADS) and Penn State Worry Questionnaire (PSWQ) scores. The HADS score has a minimum score of 0 (Low Anxiety/Depression) and maximum score of 42 (High Anxiety/Depression). The PSWQ has a minimum score of 16 (Low Worry) and a maximum score of 80 (High Worry). The composite score will therefore have a minimum score of 16 (low psychological distress) and a maximum score of 122 (greater psychological distress). These questionnaires will be completed on day 0 and day 7 by patients in both treatment arms and a composite score will be calculated.

Secondary

MeasureTime frameDescription
Acceptability of receiving miscarriage prediction score7 daysAcceptability will be assessed by sending patients who receive a miscarriage prediction score the following questions: 1. Did receiving the miscarriage prediction score help you feel more informed and prepared about your pregnancy outcome? (Yes/No, with an optional text box for further explanation.) 2. Would you recommend that other women in early pregnancy receive a miscarriage prediction score as part of their care? (Yes/No, with an optional explanation.)

Contacts

CONTACTEleanor Fleming, MBBS BSc MRCOG
eleanor.fleming@nhs.net+4420 3299 3168
CONTACTJackie Ross
PRINCIPAL_INVESTIGATORJackie Ross, FRCOG

King's College Hospital NHS Trust

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 28, 2026